ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 414 filers reported holding ENCOMPASS HEALTH CORP in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,310,000 | -43.5% | 16,000 | -43.0% | 1.04% | +111.9% |
| Q4 2020 | $2,320,000 | +7.9% | 28,054 | -15.2% | 0.49% | +39.3% |
| Q3 2020 | $2,150,000 | -27.2% | 33,090 | -30.6% | 0.35% | +21.0% |
| Q2 2020 | $2,952,000 | -56.7% | 47,666 | -55.3% | 0.29% | -59.4% |
| Q1 2020 | $6,825,000 | -28.3% | 106,593 | -22.4% | 0.71% | +9.7% |
| Q4 2019 | $9,518,000 | +9.9% | 137,399 | +0.3% | 0.65% | +9.8% |
| Q3 2019 | $8,664,000 | +594.8% | 136,920 | +595.5% | 0.59% | +470.2% |
| Q2 2019 | $1,247,000 | +5.7% | 19,686 | -2.5% | 0.10% | +5.1% |
| Q1 2019 | $1,180,000 | -84.2% | 20,197 | -83.3% | 0.10% | -82.3% |
| Q4 2018 | $7,477,000 | -68.2% | 121,184 | -59.9% | 0.56% | -52.6% |
| Q3 2018 | $23,530,000 | -4.4% | 301,858 | -16.9% | 1.18% | -6.8% |
| Q2 2018 | $24,611,000 | +100.6% | 363,427 | +69.3% | 1.26% | +52.0% |
| Q1 2018 | $12,270,000 | -25.2% | 214,621 | -35.3% | 0.83% | -3.3% |
| Q4 2017 | $16,395,000 | – | 331,823 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |